Tandem Diabetes Care Inc (TNDM) Stock Analysis

Tandem Diabetes Care Inc (TNDM) is a publicly traded company in the HEALTHCARE sector. It trades at $18.60, carries a market capitalization of $1.31B. This page summarizes the public market data, fundamentals, and frequently asked questions for TNDM, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Market Sentiment

Tandem Diabetes Care Inc currently has a Bullish sentiment score of 0.19.

About Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc. is an innovative medical device company based in San Diego, California, specializing in advanced insulin delivery technology for individuals with insulin-dependent diabetes. The company is renowned for its industry-leading products, including the t:slim X2 insulin delivery system, which integrates cutting-edge features such as automated insulin delivery and continuous glucose monitoring capabilities. With a strong commitment to enhancing the quality of life for diab...

GNG Research Analysis

GNG Research scores Tandem Diabetes Care Inc (TNDM) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for TNDM.

Frequently Asked Questions

Does TNDM pay dividends?

Tandem Diabetes Care Inc (TNDM) does not currently pay a regular dividend.

What is TNDM's market cap?

Tandem Diabetes Care Inc (TNDM) has a market capitalization of $1.31B with a current stock price of $18.60.